WeedMD Inc recently announced its new partnership with commercial retailer Fire & Flower Inc. The federally licensed producer and distributor of medical cannabis will agree to manufacture, package, and ship Revity CBD, a hemp product line coming to Fire and Flower’s Saskatchewan stores. The product is expected to be available starting August 14, 2020.
“We’re proud to be selected by Fire & Flower as the producer of its Revity CBD product line. As our first Canadian commercial extraction arrangement, we are looking forward to working with this award-winning retail-leader as it looks to expand into new product formats and strategic markets,” Angelo Tsebelis, CEO of WeedMD, said in a press release. “With our CX extraction business focused on developing high-grade concentrates from trichome-rich biomass, we anticipate a fruitful and long-term relationship with Fire & Flower.”
WeedMd will produce the product using its current high tech extraction facility, and will use the company’s own biomass as the raw ingredients for the product. The CX Industries, the subsidiary of WeedMD that runs the facility specializes in the manufacture of cannabis extracts and is already handling processes like extraction, tolling, licensing, and developing formulas in its Aylmer, Ontario facility.
“Based upon key consumer insights from our Hifyre digital retail and analytics platform, Fire & Flower is pleased to launch a wellness-focused brand in the underserved market of regulated CBD products,” Trevor Fencott, CEO of Fire & Flower, said in the release. “WeedMD has an excellent reputation of producing quality products and a track record of innovation in response to consumer preferences in the market. Revity CBD will launch in Saskatchewan and eventually nation-wide as Fire & Flower looks to expand the offerings of this consumer brand as international markets emerge.”